We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Antibiotic Resistant Salmonella Typhimurium Emerges in Africa

By LabMedica International staff writers
Posted on 14 Dec 2009
A new multi drug resistant strain of Salmonella typhimurium is causing life-threatening disease in Africa.

Genetic changes in the organism transformed this infection into a new antibiotic-resistant form of the disease. More...
The new strain, called ST313, appears to be better adapted to affect humans, is resistant to several commonly used antibiotics, and may spread from person to person.

A team of scientists studied approximately 50 samples of the bacterial DNA, extracted from blood samples of African patients with severe symptoms of infection and suffering from HIV, malaria, malnutrition, or anemia. They used these samples to produce a high-quality reference genome sequence. Based on this sequence, the team was able to look in fine detail at the genetic differences between ST313 and strains associated with milder disease symptoms across the globe.

The severe effects of ST313--invasive disease and high mortality rates--are seen predominantly in individuals with the immune compromising conditions, HIV, malaria, malnutrition, or anemia. It had been assumed that this wasn't a new deadly form of the organism but, rather, that the existing diarrhea causing strain of the pathogen was taking advantage of the weakened immune system of patients with underlying health problems to cause a more severe disease.

"When we started looking in detail at our newly completed reference genome sequence, we saw the genetic signatures that suggested it might be adapting to humans," explained Dr Robert Kingsley from the Welcome Trust Sanger Institute (Cambridge, UK). "For example, this deadly strain has lost around one in 50 of the genes found in the 'typical' S. typhimurium--a classic sign that it may be becoming more closely adapted to one host, in this case, humans."

The scientists also found patterns of genome degeneration. Six out of 10 of the regions that showed degradation in the invasive ST313 are also degraded in S. typhimurium, suggesting that the genomes have converged in their ability to thrive in the human host. This theory is supported by the finding that eroded areas of the genome tend to play important roles in the intimate interaction with cells of the human host.

The team's findings suggest that ST313 may be spreading by a new method, not seen before in S. typhimurium. The pathogen normally circulates among animals and it is introduced to humans through food poisoning. It spends much of its time in the animal hosts. However, ST313 may be passing predominantly from person to person and so can adapt more rapidly to its human hosts: it does not spend time acquiring mutations to help it thrive in the animal host; in fact, it may be losing them.

However, ST313 acquired a block of genes that make it resistant to the common antibiotics. The genes jumped into ST313 on a mobile genetic element called a transposon, bringing with it additional genes that make the strain more deadly.

The study was published in the December 8, 2009 edition of the journal Genome Research.

Related Links:
Welcome Trust Sanger Institute



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.